Trial
NCT00534703
Investigation of the Safety and Feasibility of AAV1/SERCA2a Gene Transfer in Patients With Chronic Heart Failure
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Imperial College London
Collaborators
British Heart Foundation; Leducq Foundation; Celladon Corporation
Condition
Chronic Heart Failure
Intervention
AAV1/SERCA2a
Why stopped
Early termination following Trial Steering Committee recommendation
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-02-08